The Research Institute at Lindner Center of HOPE, in affiliation with the University of Cincinnati  (UC) College of Medicine, conducts research to better prevent, diagnose and treat common mental illnesses, including mood disorders such as depression and bipolar disorder. Typically it can take up to 17 years before research findings become fully integrated into routine diagnostics and treatment. However, at Lindner Center of HOPE, research informs patient care each and every day. 

That’s because two of the most frequently cited researchers in mood disorders and co-occurring conditions -- Paul E. Keck, Jr., MD, CEO, and Susan L. McElroy, MD – have created a research-driven, landmark program for the successful treatment of mood disorders. Their team of clinical researchers has brought six pharmaceuticals to the market. Collectively, the team has published more than 800 research papers on the subject of mood disorders. They also work extensively with other leading research facilities around the country.

In addition, Lindner Center of HOPE is one of a handful of contributors to Mayo Clinic’s international Bipolar Biobank, a research resource that improves studies done on bipolar disorder. The Center is also one of ten sites chosen for a bipolar study granted by the National Institute for Mental Health (NIMH). 

Research in genetics, brain imaging, psychopharmacology and psychotherapy evidence provides new methods and treatments for even the most treatment resistant mood disorders. The staff closely integrates research studies into proven, multidisciplinary programs to benefit patients and further treatment. Patients interested in participating in specific studies apply through Lindner Center of HOPE.

Visit the Research Institute page for more information about current studies.